The Battelle Memorial Institute, a nonprofit organization based in Columbus, Ohio, is possibly the only corporation in the world known to possess both the Ames strain as well as a “national security division” offering the services of a team of “engineers, chemists, microbiologists, and aerosol scientists supported by state-of-theart laboratories to conduct research in the fields of bioaerosol science and technology.” On its Web site, Battelle calls this research group “one-of-a-kind.”
As subcontractors, Battelle scientists have made anthrax powders for use by the Army and U.S. intelligence agencies, but rarely by Fort Detrick, which specializes in vaccine development. Charles Dasey, spokesperson for the parent agency, the U.S. Army Medical Research and Materiel Command, says that as far as he is aware, the only dried anthrax spores made at Fort Detrick since it stopped making weapons were made by Battelle scientists working there for DARPA. This material, made in a biosafety level 3 suite in the Diagnostic Systems Division, contained killed Ames strain at a concentration of 326 million spores per gram—several orders of magnitude less concentrated than the Senate powder and crude by current standards.
Battelle is capable of more sophisticated work, as it also makes one of the world’s most advanced medicinal powders. Battelle’s pharmaceutical division, BattellePharma, also in Columbus, is one of the few companies anywhere developing electrostatically charged aerosols for inhalation. BattellePharma’s Web site boasts that the company’s new “electrohydrodynamic” aerosol “reliably delivers more than 80% of the drug to the lungs in a soft (isokinetic) cloud of uniformly sized particles.” Other powders, boasts the Web site, only achieve 20% or less.
None of this argues that Battelle or any of its employees made the Senate anthrax powder. But it is evidence that Battelle was a logical place to start looking for clues. Officials from Battelle and the Army declined to comment on any aspect of anthrax powder manufacture.